THOUSAND OAKS, Calif., Feb 23, 2004 -- Amgen Inc.
(Nasdaq: AMGN), the world´s largest biotechnology company, today announced
that it would broadcast over the Internet its first ever R&D Day meeting with
the investment community on Tuesday, March 23, 2004 at 8:30 a.m. EST, from New
At this meeting, Amgen will provide comprehensive detail regarding its
research and development programs. This broadcast will be available to media,
investors and the general public. The meeting is expected to last
approximately four hours.
This event can be accessed by going to Amgen´s Web site, www.amgen.com ,
and clicking on Investors, then on Amgen Events. Audio and slide
presentations will be available through the Web site. The event will be
archived and available for replay for one week after the event.
Amgen is a global biotechnology company that discovers, develops,
manufactures and markets important human therapeutics based on advances in
cellular and molecular biology.
CONTACT: Amgen, Thousand Oaks
Sabrina Johnson: (805) 447-4587 (media)
Cary Rosansky: (805) 447-1060 (investors)
SOURCE Amgen Inc.
media, Sabrina Johnson, +1-805-447-4587, or investors, Cary
Rosansky, +1-805-447-1060, both of Amgen Inc.